Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: the beta-Blocker Length Of Stay (BLOS) study.
暂无分享,去创建一个
Eugene Crystal | André Lamy | S. Connolly | M. Gent | K. Thorpe | A. Lamy | R. Roberts | S. Carroll | Stuart J Connolly | Kevin E Thorpe | Michael Gent | E. Crystal | Robin S Roberts | Irene Cybulsky | Bernard O'brien | Sandra Carroll | I. Cybulsky | B. O'brien
[1] S. Lansman,et al. Oral d,lsotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study☆ , 1999 .
[2] S. Ommen,et al. Atrial arrhythmias after cardiothoracic surgery. , 1997, The New England journal of medicine.
[3] Amiodarone to Prevent Recurrence of Atrial Fibrillation , 2000 .
[4] M. Taams,et al. Prevention and Treatment of Supraventricular Tachycardia Shortly After Coronary Artery Bypass Grafting: A Randomized Open Trial , 1986, Angiology.
[5] J. Savino,et al. Atrial fibrillation following coronary artery bypass graft surgery: Predictors, outcomes, and resource utilization , 1996 .
[6] L. Cohn,et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. , 1996, Circulation.
[7] J. Babin-Ebell,et al. Efficacy and safety of low-dose propranolol versus diltiazem in the prophylaxis of supraventricular tachyarrhythmia after coronary artery bypass grafting. , 1996, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[8] M. Galiñanes,et al. Residual atrial fibrillation and clinical consequences following postoperative supraventricular arrhythmias. , 2000, International journal of cardiology.
[9] M. Herman,et al. Predictors, prevention, and long-term prognosis of atrial fibrillation after coronary artery bypass graft operations. , 1987, The Journal of thoracic and cardiovascular surgery.
[10] R. Marinchak,et al. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. , 1992, The American journal of cardiology.
[11] J. Tijssen,et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. , 1991, The American journal of cardiology.
[12] A. Solomon. Treatment of postoperative atrial fibrillation: a nonsurgical perspective. , 1999, Seminars in thoracic and cardiovascular surgery.
[13] A. Gafni,et al. Outcomes and costs of coronary artery bypass grafting: comparison between octogenarians and septuagenarians at a tertiary care centre. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[14] P. Kowey,et al. Management and prevention of atrial fibrillation after cardiovascular surgery. , 2000, The American journal of cardiology.
[15] M. Pfisterer,et al. Significance of Supraventricular Tachyarrhythmias After Coronary Artery Bypass Graft Surgery and Their Prevention by Low-Dose Sotalol: A Prospective Double-Blind Randomized Placebo-Controlled Study , 1998, Journal of cardiovascular pharmacology and therapeutics.
[16] J. Steinberg,et al. Atrial fibrillation independently prolongs hospital stay after coronary artery bypass surgery , 2000, Clinical cardiology.
[17] S. Guyton,et al. Beta blockade to prevent atrial dysrhythmias following coronary bypass surgery. , 1997, American journal of surgery.
[18] L. Toivonen,et al. Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery. , 1998, Journal of cardiovascular pharmacology.
[19] K. Rådegran,et al. Oral Sotalol Reduces the Incidence of Atrial Fibrillation after Coronary Artery Bypass Surgery , 1993, The Thoracic and cardiovascular surgeon.
[20] R. M. Tjon Joe Gin,et al. Efficacy and safety of low- and high-dose sotalol versus propranolol in the prevention of supraventricular tachyarrhythmias early after coronary artery bypass operations. , 1990, The Journal of thoracic and cardiovascular surgery.
[21] W. O’Neill,et al. Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. , 1999, American heart journal.
[22] F. Morady. Prevention of atrial fibrillation in the postoperative cardiac patient: significance of oral class III antiarrhythmic agents. , 1999, The American journal of cardiology.
[23] R. Dion,et al. Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. , 1994, Journal of cardiothoracic and vascular anesthesia.
[24] F. Morady,et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery , 1997 .
[25] J. Alpert,et al. ACC/AHA guidelines for coronary artery bypass graft surgery , 1999 .
[26] P. Pagé,et al. Atrial fibrillation following cardiac surgery. , 2005, The Canadian journal of cardiology.
[27] T. Perneger,et al. Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery. , 2000, British journal of anaesthesia.
[28] I. Ali,et al. Beta-blocker effects on postoperative atrial fibrillation. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[29] H. Schaff,et al. Influence of clinical and hemodynamic variables on risk of supraventricular tachycardia after coronary artery bypass. , 1991, The Journal of thoracic and cardiovascular surgery.